216 related articles for article (PubMed ID: 20081228)
21. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
[TBL] [Abstract][Full Text] [Related]
22. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes.
Katanasaka Y; Sunagawa Y; Hasegawa K; Morimoto T
Biol Pharm Bull; 2013; 36(1):13-7. PubMed ID: 23302632
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
[TBL] [Abstract][Full Text] [Related]
24. FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes.
Hirai M; Ono K; Morimoto T; Kawamura T; Wada H; Kita T; Hasegawa K
J Biol Chem; 2004 Sep; 279(36):37640-50. PubMed ID: 15220332
[TBL] [Abstract][Full Text] [Related]
25. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism.
Dai YS; Cserjesi P; Markham BE; Molkentin JD
J Biol Chem; 2002 Jul; 277(27):24390-8. PubMed ID: 11994297
[TBL] [Abstract][Full Text] [Related]
26. p300-mediated histone acetylation is essential for the regulation of GATA4 and MEF2C by BMP2 in H9c2 cells.
Zheng M; Zhu J; Lu T; Liu L; Sun H; Liu Z; Tian J
Cardiovasc Toxicol; 2013 Dec; 13(4):316-22. PubMed ID: 23632743
[TBL] [Abstract][Full Text] [Related]
27. Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology.
Thompson JW; Wei J; Appau K; Wang H; Yu H; Spiga MG; Graham RM; Webster KA
PLoS One; 2015; 10(8):e0136847. PubMed ID: 26317696
[TBL] [Abstract][Full Text] [Related]
28. Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy.
Xu Y; Liang C; Luo Y; Xing W; Zhang T
J Cell Biochem; 2019 Jun; 120(6):9047-9055. PubMed ID: 30582211
[TBL] [Abstract][Full Text] [Related]
29. JNK signaling-dependent regulation of histone acetylation are involved in anacardic acid alleviates cardiomyocyte hypertrophy induced by phenylephrine.
Peng B; Peng C; Luo X; Wu S; Mao Q; Zhang H; Han X
PLoS One; 2021; 16(12):e0261388. PubMed ID: 34914791
[TBL] [Abstract][Full Text] [Related]
30. p300 Functions as a coactivator of transcription factor GATA-4.
Dai YS; Markham BE
J Biol Chem; 2001 Oct; 276(40):37178-85. PubMed ID: 11481322
[TBL] [Abstract][Full Text] [Related]
31. GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium.
Rojas A; Kong SW; Agarwal P; Gilliss B; Pu WT; Black BL
Mol Cell Biol; 2008 Sep; 28(17):5420-31. PubMed ID: 18591257
[TBL] [Abstract][Full Text] [Related]
32. Smad4 mediated BMP2 signal is essential for the regulation of GATA4 and Nkx2.5 by affecting the histone H3 acetylation in H9c2 cells.
Si L; Shi J; Gao W; Zheng M; Liu L; Zhu J; Tian J
Biochem Biophys Res Commun; 2014 Jul; 450(1):81-6. PubMed ID: 24866243
[TBL] [Abstract][Full Text] [Related]
33. Cyclins that don't cycle--cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size.
Sano M; Schneider MD
Cell Cycle; 2003; 2(2):99-104. PubMed ID: 12695656
[TBL] [Abstract][Full Text] [Related]
34. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo.
van Berlo JH; Elrod JW; Aronow BJ; Pu WT; Molkentin JD
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12331-6. PubMed ID: 21746915
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.
Bisping E; Ikeda S; Sedej M; Wakula P; McMullen JR; Tarnavski O; Sedej S; Izumo S; Pu WT; Pieske B
J Biol Chem; 2012 Mar; 287(13):9827-9834. PubMed ID: 22228770
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin-activated ERK/MAP kinase enhances GATA-4 acetylation via phosphorylation of serine 261 of GATA-4.
Jun JH; Shim JK; Ryoo HM; Kwak YL
J Cell Physiol; 2013 Jan; 228(1):190-7. PubMed ID: 22674427
[TBL] [Abstract][Full Text] [Related]
37. Effects of PM
Li R; Zhao Y; Shi J; Zhao C; Xie P; Huang W; Yong T; Cai Z
Chemosphere; 2020 Oct; 256():127133. PubMed ID: 32454355
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Cardiac Transcription Factor GATA4 by Post-Translational Modification in Cardiomyocyte Hypertrophy and Heart Failure.
Katanasaka Y; Suzuki H; Sunagawa Y; Hasegawa K; Morimoto T
Int Heart J; 2016 Dec; 57(6):672-675. PubMed ID: 27818483
[TBL] [Abstract][Full Text] [Related]
39. CDK9 and its repressor LARP7 modulate cardiomyocyte proliferation and response to injury in the zebrafish heart.
Matrone G; Wilson KS; Maqsood S; Mullins JJ; Tucker CS; Denvir MA
J Cell Sci; 2015 Dec; 128(24):4560-71. PubMed ID: 26542022
[TBL] [Abstract][Full Text] [Related]
40. DEC1 represses cardiomyocyte hypertrophy by recruiting PRP19 as an E3 ligase to promote ubiquitination-proteasome-mediated degradation of GATA4.
Cheng L; Xu C; Chen Y; Li J; Wang J; Xiao J; Ma M; Feng X; Wei X; Fang J
J Mol Cell Cardiol; 2022 Aug; 169():96-110. PubMed ID: 35659652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
